<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04722276</url>
  </required_header>
  <id_info>
    <org_study_id>2012-152-1184</org_study_id>
    <nct_id>NCT04722276</nct_id>
  </id_info>
  <brief_title>Fraction of Oxygen on Induction of Anesthesia in Infants</brief_title>
  <acronym>PEEP</acronym>
  <official_title>The Effect of Positive End-expiratory Pressure During Induction of General Anesthesia and Non-hypoxic Apnea Time in Infants: a Randomized Controlled Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We evaluated the effect of positive end-expiratory pressure during anaesthesia induction on&#xD;
      nonhypoxic apnoea time in infants. We assigned infants to a 7 cmH2O positive end expiratory&#xD;
      pressure (PEEP) with fraction of inspired oxygen 100% or 0 cmH2O PEEP with fraction of oxygen&#xD;
      80% group. Anaesthesia was induced with 0.02 mg kg atropine, 5 mg kg thiopental sodium and 3&#xD;
      to 5% sevoflurane, and neuromuscular blockade with 0.6 mg kg rocuronium. Thereafter, 100%&#xD;
      oxygen was provided via face mask with volume-controlled ventilation of 6 ml kg tidal volume,&#xD;
      and either 7 cmH2O or no positive end-expiratory pressure. After 3 min of ventilation, the&#xD;
      infants' trachea was intubated but disconnected from the breathing circuit, and ventilation&#xD;
      resumed when pulse oximetry reached 95%.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>apnea time</measure>
    <time_frame>during face mask ventilation, maximum 3 minutes.</time_frame>
    <description>The primary outcome was nonhypoxic apnoea time defined as the time from cessation of ventilation to a pulse oximeter reading of 95%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of significant atelectasis</measure>
    <time_frame>during anesthesia induction, maximum 5 minutes.</time_frame>
    <description>the incidence of significant atelectasis (consolidation score â‰¥2) assessed by lung ultrasound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory system compliance</measure>
    <time_frame>during anesthesia induction, maximum 5 minutes.</time_frame>
    <description>Respiratory system compliance (ml/H2O) = tidal volume / (airway pressure at end inspiration-airway pressure at PEEP</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Apnea</condition>
  <arm_group>
    <arm_group_label>fraction of inspired oxygen 80%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fraction of inspired oxygen 100% with positive end expiratory pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>positive end expiratory pressure</intervention_name>
    <description>7cmH2O of positive end expiratory pressure with fraction of inspired oxygen 100% applied during induction of anesthesia</description>
    <arm_group_label>Fraction of inspired oxygen 100% with positive end expiratory pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fraction of inspired oxygen 80%</intervention_name>
    <description>fraction of inspired oxygen 80% applied during induction of anesthesia</description>
    <arm_group_label>fraction of inspired oxygen 80%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  We included paediatric patients aged 12 months or less about to receive general&#xD;
             anaesthesia with endotracheal intubation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neonates, former preterm infants with gestational age less than 60 weeks at the day of&#xD;
             surgery, with previous history of respiratory disease, those with anticipated&#xD;
             difficult mask ventilation or intubation and those with upper respiratory infection&#xD;
             within 3 weeks were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hee-Soo Kim, professor</last_name>
    <phone>+82-2-2072-3664</phone>
    <email>dami0605@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hee-Soo Kim</name>
      <address>
        <city>Seoul</city>
        <state>Soul-t'ukpyolsi</state>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee-Soo Kim, MD.PhD</last_name>
      <phone>08201052878006</phone>
      <email>dami0605@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Eun-Hee Kim, MD.</last_name>
      <phone>08201099335014</phone>
      <email>beloveun@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 20, 2021</study_first_submitted>
  <study_first_submitted_qc>January 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>January 21, 2021</last_update_submitted>
  <last_update_submitted_qc>January 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Soo Kim</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

